Ustekinumab, sold under the brand name Stelara among others, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment...

program comprising four clinical trials which compared risankizumab to ustekinumab, adalimumab and placebo in the indication of plaque psoriasis. The results...

treatment with ustekinumab. It showed that patients who switched to guselkumab from ustekinumab did better than those who remained on ustekinumab. "Tremfya...

|etanercept |rheumatoid arthritis |Enbrel |7.2 |7.6 |7.9 |8.0 |8.1 |- |4 |ustekinumab |psoriasis |Stelara |2.0 |2.6 |3.7 |5.0 |6.6 |- |5 |pembrolizumab |oncology...

needed] Ustekinumab (CNTO 1275) is a monoclonal antibody that suppresses cytokines IL-12 and IL-23. Originally designed to treat psoriasis, ustekinumab was...

bimekizumab is superior to not only adalimumab but also secukinumab and ustekinumab for the treatment of plaque psoriasis. "Bimzelx APMDS". Therapeutic Goods...

such as vedolizumab and natalizumab and interleukin antagonists like ustekinumab. Prior to the development of biological therapy as a modality to treat...

received marketing authorization in 2021, and its second product, an ustekinumab biosimilar, in 2023. Products under development include biosimilars of...

Armando; Moreira, Ana Isabel (2016-05-24). "Inverse psoriasis treated with ustekinumab". BMJ Case Reports. BMJ: bcr2016215019. doi:10.1136/bcr-2016-215019....

share a common domain, p40, which is the target of the FDA-approved ustekinumab. In 2017 the US FDA approved guselkumab for plaque psoriasis. There have...

urtoxazumab (INN) usistapide (USAN, INN) ustekinumab (USAN, INN) ustekinumab-aekn ustekinumab-auub ustekinumab-ttwe utibapril (INN) utibaprilat (INN) Uticillin...

development for psoriasis has been discontinued in the U.S. and Europe. Like ustekinumab, the antibody targets the interleukins 12 and 23. The candidate drug...

showing superior skin clearance in a Phase III trial when compared to ustekinumab and a placebo. However, in May 2015, Amgen announced that it was ending...

is one of the therapeutic targets to treat the inflammatory diseases. Ustekinumab, a monoclonal antibody directed against this cytokine, is used to treat...

antibodies, such as infliximab, adalimumab, certolizumab, vedolizumab, ustekinumab, natalizumab,risankizumab-rzaa, and upadacitinib Hydrocortisone should...

certolizumab pegol and adalimumab, as well as the IL-12/IL-23 inhibitor ustekinumab, the IL-17A inhibitor secukinumab, and the IL-23 inhibitor risankizumab...

Japan for use in treating psoriatic arthritis. The anti-IL-23 antibody ustekinumab can also be used to effectively treat psoriasis by indirectly reducing...

IL-12 Agonists: Edodekin alfa Interleukin 12 Antibodies: Briakinumab Ustekinumab IL-13 Agonists: Binetrakin Cintredekin besudotox Interleukin 4 Interleukin...

and Th17 T-cells. IL-12 and IL-23 signaling is blocked by the biologic ustekinumab and IL-23 is blocked by guselkumab, mirikizumab and risankizumab, medications...

disease ulcerative colitis ankylosing spondylitis inhibits TNF-α human ustekinumab Crohn's disease ulcerative colitis plaque psoriasis psoriatic arthritis...

tocilizumab-bavi/Tofidence tocilizumab/Actemra October 2023 ustekinumab-auub/Wezlana ustekinumab/Stelara December 2023 bevacizumab-tnjn/Avzivi bevacizumab/Avastin...

history, preferences, and the recommendations of the healthcare provider. Ustekinumab has frequently been used as a second-line therapy for AS, but it has...

corticosteroids. There are also reports that the monoclonal antibody ustekinumab (which blocks IL-23/ IL-12) may be effective. List of cutaneous conditions...

WANG, Ting-Shun; TSAI, Tsen-Fang (May 4, 2011). "Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: A case series". The Journal...

IL-12 Agonists: Edodekin alfa Interleukin 12 Antibodies: Briakinumab Ustekinumab IL-13 Agonists: Binetrakin Cintredekin besudotox Interleukin 4 Interleukin...

Tocilizumab Ustekinumab Interleukin 5 Mepolizumab Immunoglobulin E Omalizumab Interferon Faralimomab IL-6 Elsilimomab IL-12 and IL-23 Lebrikizumab Ustekinumab IL-17A...

for ANTM on Oxygen. She appears in the 2012 commercial for Stelara (Ustekinumab), a plaque psoriasis treatment. English has taken part in the Seventh...

IL-12 Agonists: Edodekin alfa Interleukin 12 Antibodies: Briakinumab Ustekinumab IL-13 Agonists: Binetrakin Cintredekin besudotox Interleukin 4 Interleukin...

results for brodalumab in a Phase III trial comparing the compound with ustekinumab and a placebo in treating psoriasis.In the same month, construction was...

originate from a human. An example of a human monoclonal antibody is ustekinumab, which treats psoriasis. During the early stages of the COVID-19 pandemic...